USPTO serial 79430491
CARDIATEC BIO
Reviewed by CopyMark Law Group
Status 661
- Filing date
- Status date
- Registration date
- —
- Examiner
- BIBB, SCOTT
- Law office
- TMEG LAW OFFICE 109
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with CARDIATEC BIO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Providing online non-downloadable computer software for use in the pharmaceuticals and healthcare fields, namely, for molecular research, the research and development of pharmaceutical products and chemical compounds, cell analysis, design of chemical structures, and analysis of biological or chemical activity; Providing on-line non-downloadable software using artificial intelligence (AI) for use in the pharmaceuticals and healthcare fields, namely, for diagnostic and therapeutic use, and for data mining in connection with pharmaceutical drug discovery, drug development, pharmaceutical market access, chemogenomics, toxicogenomics and drug response prediction; providing online non-downloadable self-learning software using artificial intelligence (AI) for providing online non-downloadable software for developing cardiovascular therapies and conducting computational modeling and related research in the fields of cardiovascular disease for use in the field of healthcare; providing online non-downloadable self-learning software using artificial intelligence (AI) for providing online non-downloadable software for integrating human heart tissue data with computational models to generate scientific and medical research insights relating to cardiovascular disease biology, therapeutic targets, biomarkers, and candidate therapies for use in the field of healthcare; providing online non-downloadable software using artificial intelligence for use in the biotechnology field for discovering and designing biomolecules; contract research services in the field of molecular sciences | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 24, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 24, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 24, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 28, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 11, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 11, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 26, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 25, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 30, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 19, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 19, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 18, 2025 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Aug 21, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |